awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q21195757-C09D668E-36E3-41CB-AA57-810840C85CEF
Q21195757-C09D668E-36E3-41CB-AA57-810840C85CEF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21195757-C09D668E-36E3-41CB-AA57-810840C85CEF
First human dose-escalation study with remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2 (SGLT2), in healthy subjects and in subjects with type 2 diabetes mellitus
P2860
Q21195757-C09D668E-36E3-41CB-AA57-810840C85CEF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21195757-C09D668E-36E3-41CB-AA57-810840C85CEF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4fc504284c07dadc24ad1e0d60c07abe3f16ca9a
P2860
The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.